Hormone Replacement Therapy Safe for Women with Menopause, Cancer Survivors
Posted on: Tuesday, 28 June 2005, 16:50 CDT
June 28, 2005 - Research shows that short-term hormone replacement therapy (HRT) is appropriate for peri- and postmenopausal women. These and other results from the Women's Health Initiative (WHI), the largest, most statistically valid and well analyzed research evaluating the use of HRT, are reviewed in the International Journal of Gynecological Cancer.
In peri- and postmenopausal women who have moderate to severe vasomotor symptoms associated with estrogen deficiency, data shows that HRT can be beneficial. Although the WHI results only provided data from an oral continuous therapy, researchers say that other routes may be safer and patients should discuss the option with their doctor to weigh the risks against severity of symptoms and expected benefits.
Additionally, several studies have shown that the use of HRT in patients who are survivors from gynecologic cancer does not compromise survival, as was previously thought. Several retrospective studies have failed to demonstrate an adverse effect and the establishment of a definitive role for HRT will depend on the analysis of randomized clinical trials.
On the Internet:
Related Articles
- Hormone Therapy Plus Physical Activity Decrease Belly Fat, Body Fat Percentage After Menopause
- HRT Use Results in Small but Real Rise in Ovarian Cancer Cases, Deaths: Study
- Hormone therapy less risky for younger women-study
- Hormone Therapy Less Risky for Younger Women
- The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial
- Women Warned Hormone Therapy Can Increase Risk of Womb Cancer
- So Are You in the Danger Zone?
- HRT: Still a Useful Therapeutic Tool
- Some Hormone Replacement Therapy Has Value
- FERTILITY CONFERENCE: HRT May Help to Prolong Women's Lives
 |
 |
User Comments (0)
RSS Feeds